ID stringlengths 13 17 | question stringlengths 88 1.13k | answer stringlengths 6 156 | reference_sequence stringlengths 4.1k 4.1k | variant_sequence stringlengths 4.1k 4.1k |
|---|---|---|---|---|
Task1_train_24200 | The gene HNF1B (HNF1 homeobox B), on Chromosome 17, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; Renal cysts and diabetes syndrome | CACATAGTAGGTGCCTGTATAATAGTTACAGAAGGAAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAG... | CACATAGTAGGTGCCTGTATAATAGTTACAGAAGGAAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAG... |
Task1_train_24201 | This variant lies on Chromosome 17 and affects the gene HNF1B (HNF1 homeobox B). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause? | Pathogenic; Renal cysts and diabetes syndrome | GCCTGTATAATAGTTACAGAAGGAAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATC... | GCCTGTATAATAGTTACAGAAGGAAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATC... |
Task1_train_24202 | This alteration occurs within gene HNF1B (HNF1 homeobox B) located on Chromosome 17. Is it associated with a disease or is it a benign variant? | Pathogenic; Renal cysts and diabetes syndrome | ATAGTTACAGAAGGAAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTG... | ATAGTTACAGAAGGAAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTG... |
Task1_train_24203 | A variant on Chromosome 17 in gene HNF1B (HNF1 homeobox B) has been observed. Is this a neutral mutation, or does it result in a disease? If so, which one? | Pathogenic; Renal cysts and diabetes syndrome | AAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGG... | AAGGAATGTTTCTTAAGCTTTTATGTCTCGTGTGACTTTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGG... |
Task1_train_24204 | Given this variant in gene HNF1B (HNF1 homeobox B) on Chromosome 17, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; Renal cysts and diabetes syndrome | TTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGGTGGCAGAGCGAGACCCCGTCTCAAAAAGTTAAATAAA... | TTAAAACAAAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGGTGGCAGAGCGAGACCCCGTCTCAAAAAGTTAAATAAA... |
Task1_train_24205 | The gene HNF1B (HNF1 homeobox B) on Chromosome 17 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; Renal cysts and diabetes syndrome | AAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGGTGGCAGAGCGAGACCCCGTCTCAAAAAGTTAAATAAATAAATAAA... | AAAATAACAACTGGGTGCGGTGGCTCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGGTGGCAGAGCGAGACCCCGTCTCAAAAAGTTAAATAAATAAATAAA... |
Task1_train_24206 | This sequence change occurs on Chromosome 17, altering HNF1B (HNF1 homeobox B). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Renal cysts and diabetes syndrome | TCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGGTGGCAGAGCGAGACCCCGTCTCAAAAAGTTAAATAAATAAATAAATAAATAAAACAAAAATAACAATAA... | TCACCCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGCGGATCACGAGGTCAGGAGATCAAGACCAGCCTGGCCAACATAGTGAAACCCCGTCTCTACTAAAAATACCAAAAAAAAAAAAAATTAGCCAGGTGTGGTGGCGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAAGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGTCTGGGTGGCAGAGCGAGACCCCGTCTCAAAAAGTTAAATAAATAAATAAATAAATAAAACAAAAATAACAATAA... |
Task1_train_24207 | Chromosome 17 houses a mutation in gene HNF1B (HNF1 homeobox B). Classify its clinical impact — is it pathogenic or benign, and what disease does it lead to if any? | Pathogenic; Renal cysts and diabetes syndrome | CCTAGGAACCGCTAGCGATTTCTTGAAAAATTACTTTAATCAAGTCCGGCGCTCCCGGGAGCGGGGGAGGAAAGGCAGCACCCGCTCGGGACGGGAGAAAAAAGCCTCCAGGTCTGTCCCGCGTCTCCAACTCGGCGAGGGTCTCCGGCTCCCCAGTCCCTCTCCCTGCCCTGCTGGGGCCTGGGGCTTTGGGGAGGGAAGAGCGGGGCTGGGGTCTAAGGACCCTGGGCCGGGCCTGGCTCTCCGCCGGCCGGGCCTGCGGGTGTCGGCGACCCGGGGGCTCCGCGGGCGGCTCGGGCGCTCACAGAGCCCGCGTCCCG... | CCTAGGAACCGCTAGCGATTTCTTGAAAAATTACTTTAATCAAGTCCGGCGCTCCCGGGAGCGGGGGAGGAAAGGCAGCACCCGCTCGGGACGGGAGAAAAAAGCCTCCAGGTCTGTCCCGCGTCTCCAACTCGGCGAGGGTCTCCGGCTCCCCAGTCCCTCTCCCTGCCCTGCTGGGGCCTGGGGCTTTGGGGAGGGAAGAGCGGGGCTGGGGTCTAAGGACCCTGGGCCGGGCCTGGCTCTCCGCCGGCCGGGCCTGCGGGTGTCGGCGACCCGGGGGCTCCGCGGGCGGCTCGGGCGCTCACAGAGCCCGCGTCCCG... |
Task1_train_24208 | A mutation on Chromosome 17 affecting HNF1B (HNF1 homeobox B) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Maturity onset diabetes mellitus in young | TGTCCCGCGTCTCCAACTCGGCGAGGGTCTCCGGCTCCCCAGTCCCTCTCCCTGCCCTGCTGGGGCCTGGGGCTTTGGGGAGGGAAGAGCGGGGCTGGGGTCTAAGGACCCTGGGCCGGGCCTGGCTCTCCGCCGGCCGGGCCTGCGGGTGTCGGCGACCCGGGGGCTCCGCGGGCGGCTCGGGCGCTCACAGAGCCCGCGTCCCGCGCCAGAGCGGTGAGGCCGCAGGGCCGCACGGGGCGCCTGGCTGGGTGCGCGCTGGGAGCGGCGAGCAGCCCCGCGCCCGCGTTTTGATCTCCTTCCCCCCTCTAAGCCGCGTT... | TGTCCCGCGTCTCCAACTCGGCGAGGGTCTCCGGCTCCCCAGTCCCTCTCCCTGCCCTGCTGGGGCCTGGGGCTTTGGGGAGGGAAGAGCGGGGCTGGGGTCTAAGGACCCTGGGCCGGGCCTGGCTCTCCGCCGGCCGGGCCTGCGGGTGTCGGCGACCCGGGGGCTCCGCGGGCGGCTCGGGCGCTCACAGAGCCCGCGTCCCGCGCCAGAGCGGTGAGGCCGCAGGGCCGCACGGGGCGCCTGGCTGGGTGCGCGCTGGGAGCGGCGAGCAGCCCCGCGCCCGCGTTTTGATCTCCTTCCCCCCTCTAAGCCGCGTT... |
Task1_train_24209 | A mutation in HNF1B (HNF1 homeobox B), located on Chromosome 17, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Renal cysts and diabetes syndrome | GAGGCCGCAGGGCCGCACGGGGCGCCTGGCTGGGTGCGCGCTGGGAGCGGCGAGCAGCCCCGCGCCCGCGTTTTGATCTCCTTCCCCCCTCTAAGCCGCGTTTACAACTTCACCAATGAATAACCCGCCTCTCTTTTCAACCTAATCACGGCTCTTTGTGTATCTTTCTGTTGATGATTTATAGAAATAAATTAATAACACCCCAACTCCACGTGCTGCAGTTTATGTTACGTCTCAGCTGCGGCCAGCCCGGCGCGGGGCTGGGTGCGGAGGGGCGCCCCAGGTCCTTCCAGCGCCGCGCTAGAAAGCGGGCGCCTGCG... | GAGGCCGCAGGGCCGCACGGGGCGCCTGGCTGGGTGCGCGCTGGGAGCGGCGAGCAGCCCCGCGCCCGCGTTTTGATCTCCTTCCCCCCTCTAAGCCGCGTTTACAACTTCACCAATGAATAACCCGCCTCTCTTTTCAACCTAATCACGGCTCTTTGTGTATCTTTCTGTTGATGATTTATAGAAATAAATTAATAACACCCCAACTCCACGTGCTGCAGTTTATGTTACGTCTCAGCTGCGGCCAGCCCGGCGCGGGGCTGGGTGCGGAGGGGCGCCCCAGGTCCTTCCAGCGCCGCGCTAGAAAGCGGGCGCCTGCG... |
Task1_train_24210 | Here is a mutation in HNF1B (HNF1 homeobox B) on Chromosome 17. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Renal cysts and diabetes syndrome | GAGGCCGCAGGGCCGCACGGGGCGCCTGGCTGGGTGCGCGCTGGGAGCGGCGAGCAGCCCCGCGCCCGCGTTTTGATCTCCTTCCCCCCTCTAAGCCGCGTTTACAACTTCACCAATGAATAACCCGCCTCTCTTTTCAACCTAATCACGGCTCTTTGTGTATCTTTCTGTTGATGATTTATAGAAATAAATTAATAACACCCCAACTCCACGTGCTGCAGTTTATGTTACGTCTCAGCTGCGGCCAGCCCGGCGCGGGGCTGGGTGCGGAGGGGCGCCCCAGGTCCTTCCAGCGCCGCGCTAGAAAGCGGGCGCCTGCG... | GAGGCCGCAGGGCCGCACGGGGCGCCTGGCTGGGTGCGCGCTGGGAGCGGCGAGCAGCCCCGCGCCCGCGTTTTGATCTCCTTCCCCCCTCTAAGCCGCGTTTACAACTTCACCAATGAATAACCCGCCTCTCTTTTCAACCTAATCACGGCTCTTTGTGTATCTTTCTGTTGATGATTTATAGAAATAAATTAATAACACCCCAACTCCACGTGCTGCAGTTTATGTTACGTCTCAGCTGCGGCCAGCCCGGCGCGGGGCTGGGTGCGGAGGGGCGCCCCAGGTCCTTCCAGCGCCGCGCTAGAAAGCGGGCGCCTGCG... |
Task1_train_24211 | The following genetic variant occurs in GPR179 (G protein-coupled receptor 179) on Chromosome 17. Classify its clinical effect — pathogenic or benign — and list any associated condition. | Pathogenic; Congenital stationary night blindness 1E | CAGGTGTAAATGATGGAACGGGGCTTTAGAAGTCTTCTGTTCTGGGTTTCTCCCCAGATCCAGCATAGGGGCCGCAGATTGGCTTGTGTTCCAGAAAGTGGAGGGTCAGGGGTGGAGCTGCCCCTCCATACTCCCTGGCCCTTCAGCTGGATTGGGGTCTCAGGAGGCAGGGCAGGCAGAGCTCAGAGGGTGAGGACACAAGGGGGAAACGGGCAGAGGCACTGGAACAAGGAAGGACTCAGGAGATGCAGAGGACTCTGCTTTGTGGGCCTGTAAACAAGTCAGGTGTGAAGACGGCCCCAGTAGAGGTGGAGGGGGTG... | CAGGTGTAAATGATGGAACGGGGCTTTAGAAGTCTTCTGTTCTGGGTTTCTCCCCAGATCCAGCATAGGGGCCGCAGATTGGCTTGTGTTCCAGAAAGTGGAGGGTCAGGGGTGGAGCTGCCCCTCCATACTCCCTGGCCCTTCAGCTGGATTGGGGTCTCAGGAGGCAGGGCAGGCAGAGCTCAGAGGGTGAGGACACAAGGGGGAAACGGGCAGAGGCACTGGAACAAGGAAGGACTCAGGAGATGCAGAGGACTCTGCTTTGTGGGCCTGTAAACAAGTCAGGTGTGAAGACGGCCCCAGTAGAGGTGGAGGGGGTG... |
Task1_train_24212 | A genetic alteration is present in NEUROD2 (neuronal differentiation 2) on Chromosome 17. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Developmental and epileptic encephalopathy, 72 | GTGGGGCTGCCCCCAGGTCTCCATCCCCACCCCTCACCCCAGGAGGGGACAGAATGGCCGCGGGGAGGAGGAGCCGGCGAGCTCACCTCCTTCTGCCCCCCGGACGCCGGCGCCGGGCCTGCTTGTGCGTGCGGTGTGGTGTGCGTGTGTCTTTCATGCAAACCCTCCCTCCCCAAACCGACCCCCCAACAGTTTGCCATTCCATACAAATTTGGAAACAGGTTTTTAAAAAACAGCATGACGCACAACGGGGACGGGGCGGGGGAGGGCAGTGGCACTGGGGCCCCAAATCTCCGAGTCACTGATTGTAAGAACCTGGG... | GTGGGGCTGCCCCCAGGTCTCCATCCCCACCCCTCACCCCAGGAGGGGACAGAATGGCCGCGGGGAGGAGGAGCCGGCGAGCTCACCTCCTTCTGCCCCCCGGACGCCGGCGCCGGGCCTGCTTGTGCGTGCGGTGTGGTGTGCGTGTGTCTTTCATGCAAACCCTCCCTCCCCAAACCGACCCCCCAACAGTTTGCCATTCCATACAAATTTGGAAACAGGTTTTTAAAAAACAGCATGACGCACAACGGGGACGGGGCGGGGGAGGGCAGTGGCACTGGGGCCCCAAATCTCCGAGTCACTGATTGTAAGAACCTGGG... |
Task1_train_24213 | This sequence change occurs on Chromosome 17, altering NEUROD2 (neuronal differentiation 2). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Developmental and epileptic encephalopathy, 72 | CAGGTCTCCATCCCCACCCCTCACCCCAGGAGGGGACAGAATGGCCGCGGGGAGGAGGAGCCGGCGAGCTCACCTCCTTCTGCCCCCCGGACGCCGGCGCCGGGCCTGCTTGTGCGTGCGGTGTGGTGTGCGTGTGTCTTTCATGCAAACCCTCCCTCCCCAAACCGACCCCCCAACAGTTTGCCATTCCATACAAATTTGGAAACAGGTTTTTAAAAAACAGCATGACGCACAACGGGGACGGGGCGGGGGAGGGCAGTGGCACTGGGGCCCCAAATCTCCGAGTCACTGATTGTAAGAACCTGGGGAGGGGGAGGGGG... | CAGGTCTCCATCCCCACCCCTCACCCCAGGAGGGGACAGAATGGCCGCGGGGAGGAGGAGCCGGCGAGCTCACCTCCTTCTGCCCCCCGGACGCCGGCGCCGGGCCTGCTTGTGCGTGCGGTGTGGTGTGCGTGTGTCTTTCATGCAAACCCTCCCTCCCCAAACCGACCCCCCAACAGTTTGCCATTCCATACAAATTTGGAAACAGGTTTTTAAAAAACAGCATGACGCACAACGGGGACGGGGCGGGGGAGGGCAGTGGCACTGGGGCCCCAAATCTCCGAGTCACTGATTGTAAGAACCTGGGGAGGGGGAGGGGG... |
Task1_train_24214 | This variant impacts the gene NEUROD2 (neuronal differentiation 2) on Chromosome 17. Is the change likely to result in a pathogenic outcome? | Pathogenic; not provided | CAGGTCTCCATCCCCACCCCTCACCCCAGGAGGGGACAGAATGGCCGCGGGGAGGAGGAGCCGGCGAGCTCACCTCCTTCTGCCCCCCGGACGCCGGCGCCGGGCCTGCTTGTGCGTGCGGTGTGGTGTGCGTGTGTCTTTCATGCAAACCCTCCCTCCCCAAACCGACCCCCCAACAGTTTGCCATTCCATACAAATTTGGAAACAGGTTTTTAAAAAACAGCATGACGCACAACGGGGACGGGGCGGGGGAGGGCAGTGGCACTGGGGCCCCAAATCTCCGAGTCACTGATTGTAAGAACCTGGGGAGGGGGAGGGGG... | CAGGTCTCCATCCCCACCCCTCACCCCAGGAGGGGACAGAATGGCCGCGGGGAGGAGGAGCCGGCGAGCTCACCTCCTTCTGCCCCCCGGACGCCGGCGCCGGGCCTGCTTGTGCGTGCGGTGTGGTGTGCGTGTGTCTTTCATGCAAACCCTCCCTCCCCAAACCGACCCCCCAACAGTTTGCCATTCCATACAAATTTGGAAACAGGTTTTTAAAAAACAGCATGACGCACAACGGGGACGGGGCGGGGGAGGGCAGTGGCACTGGGGCCCCAAATCTCCGAGTCACTGATTGTAAGAACCTGGGGAGGGGGAGGGGG... |
Task1_train_24215 | Gene TCAP (titin-cap) on Chromosome 17 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Hypertrophic cardiomyopathy 25 | GGGCCAGGCCACTGCCTGCCTTCCTCCTCCCTCCCGGCTGGCCTGCCCCCTTGCCTGCCTGCATGCAGGCTTCCAGCAGAGCCAGCTTCTTCAGAGCCAGGTGGATCCTGTTTCGGTCCTGCCTAGGTGTGTGACCCTGGGCGAATCTACCTCTCTCAGCTTCTGCTTCCCACTTTATGAAAATGGGACTGATGTCACAGGGTTGTTATGAGATTAAAAGATATGAAGAACCGGGGACAGTGCTCAGTAATCAATAGTCTGCAGTTCTGCACCCACGTGCTCCTGGGTACTCTGCCGTCCCCACAGGGTCCTCAGCTCAG... | GGGCCAGGCCACTGCCTGCCTTCCTCCTCCCTCCCGGCTGGCCTGCCCCCTTGCCTGCCTGCATGCAGGCTTCCAGCAGAGCCAGCTTCTTCAGAGCCAGGTGGATCCTGTTTCGGTCCTGCCTAGGTGTGTGACCCTGGGCGAATCTACCTCTCTCAGCTTCTGCTTCCCACTTTATGAAAATGGGACTGATGTCACAGGGTTGTTATGAGATTAAAAGATATGAAGAACCGGGGACAGTGCTCAGTAATCAATAGTCTGCAGTTCTGCACCCACGTGCTCCTGGGTACTCTGCCGTCCCCACAGGGTCCTCAGCTCAG... |
Task1_train_24216 | The gene PGAP3 (post-GPI attachment to proteins phospholipase 3) is located on Chromosome 17, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Hyperphosphatasia with intellectual disability syndrome 4 | GGACCTGCCCCTGCCGCCACAACTGTCTTCTCCTGCCCTCCAGCCCACCCTATTCACACAAATGAGCTGAACAAGGGCAGGTGAGGCTTGGAATTGATTTATTAAGCACATCCCTTGCCACCCTCCCACCTTAAAAGTTTTCAGTATCAAAAGAAGCTAGCGCAGGCCACCCGAGTCCCTGAGGTTGGAGTCCTAGCATAGCTCCCCTCCCTCAAAGAGGGACAAGGGGTCAGGGGCAGAGCAAAAATCCAGTCTGCTTCAACCACGGAGACTGCCTTTGGGATGGAAAGTTTCTGGAGCTCCCTCCATTCTATTCCTGT... | GGACCTGCCCCTGCCGCCACAACTGTCTTCTCCTGCCCTCCAGCCCACCCTATTCACACAAATGAGCTGAACAAGGGCAGGTGAGGCTTGGAATTGATTTATTAAGCACATCCCTTGCCACCCTCCCACCTTAAAAGTTTTCAGTATCAAAAGAAGCTAGCGCAGGCCACCCGAGTCCCTGAGGTTGGAGTCCTAGCATAGCTCCCCTCCCTCAAAGAGGGACAAGGGGTCAGGGGCAGAGCAAAAATCCAGTCTGCTTCAACCACGGAGACTGCCTTTGGGATGGAAAGTTTCTGGAGCTCCCTCCATTCTATTCCTGT... |
Task1_train_24217 | This gene mutation involves PGAP3 (post-GPI attachment to proteins phospholipase 3) on Chromosome 17. Is it associated with any clinical condition, or is it benign? | Pathogenic; Hyperphosphatasia with intellectual disability syndrome 4 | CCACAACTGTCTTCTCCTGCCCTCCAGCCCACCCTATTCACACAAATGAGCTGAACAAGGGCAGGTGAGGCTTGGAATTGATTTATTAAGCACATCCCTTGCCACCCTCCCACCTTAAAAGTTTTCAGTATCAAAAGAAGCTAGCGCAGGCCACCCGAGTCCCTGAGGTTGGAGTCCTAGCATAGCTCCCCTCCCTCAAAGAGGGACAAGGGGTCAGGGGCAGAGCAAAAATCCAGTCTGCTTCAACCACGGAGACTGCCTTTGGGATGGAAAGTTTCTGGAGCTCCCTCCATTCTATTCCTGTGGGGCAGGAACATGCC... | CCACAACTGTCTTCTCCTGCCCTCCAGCCCACCCTATTCACACAAATGAGCTGAACAAGGGCAGGTGAGGCTTGGAATTGATTTATTAAGCACATCCCTTGCCACCCTCCCACCTTAAAAGTTTTCAGTATCAAAAGAAGCTAGCGCAGGCCACCCGAGTCCCTGAGGTTGGAGTCCTAGCATAGCTCCCCTCCCTCAAAGAGGGACAAGGGGTCAGGGGCAGAGCAAAAATCCAGTCTGCTTCAACCACGGAGACTGCCTTTGGGATGGAAAGTTTCTGGAGCTCCCTCCATTCTATTCCTGTGGGGCAGGAACATGCC... |
Task1_train_24218 | A variant was discovered in gene PGAP3 (post-GPI attachment to proteins phospholipase 3), Chromosome 17. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Hyperphosphatasia with intellectual disability syndrome 4 | CAACTGTCTTCTCCTGCCCTCCAGCCCACCCTATTCACACAAATGAGCTGAACAAGGGCAGGTGAGGCTTGGAATTGATTTATTAAGCACATCCCTTGCCACCCTCCCACCTTAAAAGTTTTCAGTATCAAAAGAAGCTAGCGCAGGCCACCCGAGTCCCTGAGGTTGGAGTCCTAGCATAGCTCCCCTCCCTCAAAGAGGGACAAGGGGTCAGGGGCAGAGCAAAAATCCAGTCTGCTTCAACCACGGAGACTGCCTTTGGGATGGAAAGTTTCTGGAGCTCCCTCCATTCTATTCCTGTGGGGCAGGAACATGCCAGG... | CAACTGTCTTCTCCTGCCCTCCAGCCCACCCTATTCACACAAATGAGCTGAACAAGGGCAGGTGAGGCTTGGAATTGATTTATTAAGCACATCCCTTGCCACCCTCCCACCTTAAAAGTTTTCAGTATCAAAAGAAGCTAGCGCAGGCCACCCGAGTCCCTGAGGTTGGAGTCCTAGCATAGCTCCCCTCCCTCAAAGAGGGACAAGGGGTCAGGGGCAGAGCAAAAATCCAGTCTGCTTCAACCACGGAGACTGCCTTTGGGATGGAAAGTTTCTGGAGCTCCCTCCATTCTATTCCTGTGGGGCAGGAACATGCCAGG... |
Task1_train_24219 | A variant affecting Chromosome 17, within the gene PGAP3 (post-GPI attachment to proteins phospholipase 3), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Hyperphosphatasia with intellectual disability syndrome 4 | ACACACACTTTGAAGCCACACCTCTTCCCCGACAACACCCGTCTCCACACTGCGCACCTAGGCCTGAGCTCACACACACCCAGGCCCATGCTCACGGCCCTGTCACCTATGCACTCAGCCTGGCCCACACTCCCGACACACGGTGGCAGGCTCTCAACCAGACAGCAGCACAGGATCCTTGCCCTGGGCTTGCTGGAGCCCTGGCCCTGAAAGGGAGTATGGTGAGGCCTCCTGGGAACCTGGCTAGGGCAATGGTCAGGGTGAAACTCCTTCCCAATCCCAGCAGCTTGGTCCCTCAAGATCCCATGGGGAGAATCGCC... | ACACACACTTTGAAGCCACACCTCTTCCCCGACAACACCCGTCTCCACACTGCGCACCTAGGCCTGAGCTCACACACACCCAGGCCCATGCTCACGGCCCTGTCACCTATGCACTCAGCCTGGCCCACACTCCCGACACACGGTGGCAGGCTCTCAACCAGACAGCAGCACAGGATCCTTGCCCTGGGCTTGCTGGAGCCCTGGCCCTGAAAGGGAGTATGGTGAGGCCTCCTGGGAACCTGGCTAGGGCAATGGTCAGGGTGAAACTCCTTCCCAATCCCAGCAGCTTGGTCCCTCAAGATCCCATGGGGAGAATCGCC... |
Task1_train_24220 | This variant affects gene PGAP3 (post-GPI attachment to proteins phospholipase 3) located on Chromosome 17. Evaluate its biological effect and specify any disease association. | Pathogenic; Hyperphosphatasia with intellectual disability syndrome 4 | CTGGTCTACTGCATCCACTCCCGCCCCCTTCAATCTGTTCTCTACACAGTAGCCAGAATGAGCTTTCCAAAGGGCAAATCTATTCATGAAACAACTTTTCTCCTCAACCCTCATTTAAAATCCCTCCGTAGGCCGAGCACGGTGGCTGATGCCTGTAATCCCAGCACTTTGGGAGGGTGAGGTGGGCGGATCACGAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATAGTGAAACCCCATCTCTACTAAAAATACAAAAATTAGCCAGGCATGGTGGCACATGCCTGTAGTCCCAGCTGCTCAGGAGGCTGAGGCAGGA... | CTGGTCTACTGCATCCACTCCCGCCCCCTTCAATCTGTTCTCTACACAGTAGCCAGAATGAGCTTTCCAAAGGGCAAATCTATTCATGAAACAACTTTTCTCCTCAACCCTCATTTAAAATCCCTCCGTAGGCCGAGCACGGTGGCTGATGCCTGTAATCCCAGCACTTTGGGAGGGTGAGGTGGGCGGATCACGAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATAGTGAAACCCCATCTCTACTAAAAATACAAAAATTAGCCAGGCATGGTGGCACATGCCTGTAGTCCCAGCTGCTCAGGAGGCTGAGGCAGGA... |
Task1_train_24221 | The gene PGAP3 (post-GPI attachment to proteins phospholipase 3) on Chromosome 17 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Hyperphosphatasia with intellectual disability syndrome 4 | ACTTTGGGAGGCCGAGGTGGGTGGATCACCTGAGGTTGGGAGTTCGAGACCAGCCTGACCAACATGGAGAAACCCCGTCTCTACTAAAAATACAAAATTAGCCAGGTGTGGTGGCACGCGCCTATCATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGTGGAGGTTGCAGTGAGCCAAGATTGCGCCATTTGCACTCCAGCCTGGGTGACACAGTGAGACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGACTAGGCTGAGCTCTACACAGAGACTATGGCTGTGACTCCCCA... | ACTTTGGGAGGCCGAGGTGGGTGGATCACCTGAGGTTGGGAGTTCGAGACCAGCCTGACCAACATGGAGAAACCCCGTCTCTACTAAAAATACAAAATTAGCCAGGTGTGGTGGCACGCGCCTATCATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGTGGAGGTTGCAGTGAGCCAAGATTGCGCCATTTGCACTCCAGCCTGGGTGACACAGTGAGACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGACTAGGCTGAGCTCTACACAGAGACTATGGCTGTGACTCCCCA... |
Task1_train_24222 | Gene ERBB2 (erb-b2 receptor tyrosine kinase 2) on Chromosome 17 is altered by this variant. Does this mutation result in a disease or is it benign? | Pathogenic; not provided | AGGGAAGGGGAGGGCTGGGGCCGGGTGGAATGCAGGTGTCATACAGGTGACATGGGAGGGGTGGGATAACAGGCTTGGGATGTCTCCCCTGGGCCAGGTAGTCTCCCTAGAAGGTGATGCTGATGAGGGTCTGGTGCCCAGGGCGCCACTCAGCCCTCATCCTGCCCTTTGCCCAACAGTGACGCGCACTGTCTGTGCCGGTGGCTGTGCCCGCTGCAAGGGGCCACTGCCCACTGACTGCTGCCATGAGCAGTGTGCTGCCGGCTGCACGGGCCCCAAGCACTCTGACTGCCTGGTATGTGCCTCTGCTTTGTGCCCAA... | AGGGAAGGGGAGGGCTGGGGCCGGGTGGAATGCAGGTGTCATACAGGTGACATGGGAGGGGTGGGATAACAGGCTTGGGATGTCTCCCCTGGGCCAGGTAGTCTCCCTAGAAGGTGATGCTGATGAGGGTCTGGTGCCCAGGGCGCCACTCAGCCCTCATCCTGCCCTTTGCCCAACAGTGACGCGCACTGTCTGTGCCGGTGGCTGTGCCCGCTGCAAGGGGCCACTGCCCACTGACTGCTGCCATGAGCAGTGTGCTGCCGGCTGCACGGGCCCCAAGCACTCTGACTGCCTGGTATGTGCCTCTGCTTTGTGCCCAA... |
Task1_train_24223 | This variant affects gene ERBB2 (erb-b2 receptor tyrosine kinase 2) located on Chromosome 17. Evaluate its biological effect and specify any disease association. | Pathogenic; Visceral neuropathy, familial, 2, autosomal recessive | CAAAGTGCTGGGATTACAGGTGTGAGCCATCGTGCCTGGCGGAGCCGAGTCTTAAAAGATGACCCTGTGGAGAAATGGTGGTCCAGGCTGAAGGGACAGCCTATGCAAACACTGGGAGGTGTGGAAAATCATGACCTGTGGGTGGAAATTTTGGCTAGAACATCAAAATCATCAGGTGTACATTCCTGTACCCATGCAGCAGTCAGAATCTCTGGGGGTGGGGCCCCAAAATTGTATGCATACAGACTGTGTGCTGATTTGTGATATTACTTAGGATTTTTTGACTTTACAATGGTGGAAAAGCAATAATATACATTCAG... | CAAAGTGCTGGGATTACAGGTGTGAGCCATCGTGCCTGGCGGAGCCGAGTCTTAAAAGATGACCCTGTGGAGAAATGGTGGTCCAGGCTGAAGGGACAGCCTATGCAAACACTGGGAGGTGTGGAAAATCATGACCTGTGGGTGGAAATTTTGGCTAGAACATCAAAATCATCAGGTGTACATTCCTGTACCCATGCAGCAGTCAGAATCTCTGGGGGTGGGGCCCCAAAATTGTATGCATACAGACTGTGTGCTGATTTGTGATATTACTTAGGATTTTTTGACTTTACAATGGTGGAAAAGCAATAATATACATTCAG... |
Task1_train_24224 | Given this context: Chromosome 17, gene ERBB2 (erb-b2 receptor tyrosine kinase 2) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Lung adenocarcinoma | CTGATTGCCTACAAGGAGTTTGGACTTTATTGTGGAGGCAGCGGGGAGCCAAGGCAGGTTTTAGAGTAGGAGAGGGTCCAAGCCTGTGGGTCACCCTTCCGACTTCCCTTTCCGAATGCCAAACACCTTCATGTCCCCCGTGGGCCCCCTTTGTCCCTCCCACCCCAAACTAGCCCTCAATCCCTGACCCTGGCTTCCGCCCCCAGCCCTCTGACGTCCATCATCTCTGCGGTGGTTGGCATTCTGCTGGTCGTGGTCTTGGGGGTGGTCTTTGGGATCCTCATCAAGCGACGGCAGCAGAAGATCCGGAAGTACACGAT... | CTGATTGCCTACAAGGAGTTTGGACTTTATTGTGGAGGCAGCGGGGAGCCAAGGCAGGTTTTAGAGTAGGAGAGGGTCCAAGCCTGTGGGTCACCCTTCCGACTTCCCTTTCCGAATGCCAAACACCTTCATGTCCCCCGTGGGCCCCCTTTGTCCCTCCCACCCCAAACTAGCCCTCAATCCCTGACCCTGGCTTCCGCCCCCAGCCCTCTGACGTCCATCATCTCTGCGGTGGTTGGCATTCTGCTGGTCGTGGTCTTGGGGGTGGTCTTTGGGATCCTCATCAAGCGACGGCAGCAGAAGATCCGGAAGTACACGAT... |
Task1_train_24225 | This mutation occurs in ERBB2 (erb-b2 receptor tyrosine kinase 2) on Chromosome 17. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Glioma susceptibility 1 | TCCTGGGGTGGGCGGCCCCAGAGGATGGGGGCGGTGCCTGGAGGGGTGTGGTCGGCAGTTCTGATGGGAGGGGCAAGAGCTGGAGGCAGTGTTTGGGGGAGGGCAGTTACAGCGGAGAAGGGAGCGGGGCCAAGCCCTAGGGTGGTGAAGGATGTTTGGAGGACAAGTAATGATCTCCTGGAAGGCAGGTAGGATCCAGCCCACGCTCTTCTCACTCATATCCTCCTCTTTCTGCCCAGGGCATCTGGATCCCTGATGGGGAGAATGTGAAAATTCCAGTGGCCATCAAAGTGTTGAGGGAAAACACATCCCCCAAAGCC... | TCCTGGGGTGGGCGGCCCCAGAGGATGGGGGCGGTGCCTGGAGGGGTGTGGTCGGCAGTTCTGATGGGAGGGGCAAGAGCTGGAGGCAGTGTTTGGGGGAGGGCAGTTACAGCGGAGAAGGGAGCGGGGCCAAGCCCTAGGGTGGTGAAGGATGTTTGGAGGACAAGTAATGATCTCCTGGAAGGCAGGTAGGATCCAGCCCACGCTCTTCTCACTCATATCCTCCTCTTTCTGCCCAGGGCATCTGGATCCCTGATGGGGAGAATGTGAAAATTCCAGTGGCCATCAAAGTGTTGAGGGAAAACACATCCCCCAAAGCC... |
Task1_train_24226 | The gene IKZF3 (IKAROS family zinc finger 3) on Chromosome 17 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; Immunodeficiency 84 | CCTGGGAGGTGGAGGTTGCAGTGGGCTGAGATTGCACCACTGCATCCCAGCCTGGGCGGCAGAGTGAGACTCCATCTCAAACAAACAAACAAAATTAGCCGGGCGTCGTGGTAGGCATCTATAATCCCAGCTACTAGGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGTAGAGGTTGCAGTGAGCTGAGATGGCGCCGCTGTACTCCAGCCTGGGTGACAGAGTGAGACACCATCTCAAACAAACAAACAAACAAACAAAATTAGCTGGGCGTTGTGGTAGGCATCTATAATCCCAGCTACTAGGGAGGCTGAG... | CCTGGGAGGTGGAGGTTGCAGTGGGCTGAGATTGCACCACTGCATCCCAGCCTGGGCGGCAGAGTGAGACTCCATCTCAAACAAACAAACAAAATTAGCCGGGCGTCGTGGTAGGCATCTATAATCCCAGCTACTAGGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGTAGAGGTTGCAGTGAGCTGAGATGGCGCCGCTGTACTCCAGCCTGGGTGACAGAGTGAGACACCATCTCAAACAAACAAACAAACAAACAAAATTAGCTGGGCGTTGTGGTAGGCATCTATAATCCCAGCTACTAGGGAGGCTGAG... |
Task1_train_24227 | Here is a genetic alteration in THRA (thyroid hormone receptor alpha) on Chromosome 17. Based on the data, is it a benign variant or a cause of disease? | Pathogenic; Congenital nongoitrous hypothyroidism 6 | GCTCCCCTCCCCCAAAGCCTCACCCCAGGAAGGACTCTGAGGACGATCTGGCCTGTCGCTGTGTGGCTGTCACTTGCAGCCCCTGTGTCTCCCAGCTTAGGCTTCTGTGGGTCTGGAAGAGTCTGTGCTTAATGTTTGGAGAAAGGCAGGAATGCCAGTTCCCAGTCTCCTAAGACTGCAACCCCTCCCCCATCACCTTCCCCTCCCCCATGTCTATGCGCCACCTTGTGGCTATCTCTAGGACTACACTCAGAGGCTGTGAGTCTGGTGGTAACTGCTGAAGCCGCTAGCTCAACTGGGGCCTAGGTGGGCTGAGTTCC... | GCTCCCCTCCCCCAAAGCCTCACCCCAGGAAGGACTCTGAGGACGATCTGGCCTGTCGCTGTGTGGCTGTCACTTGCAGCCCCTGTGTCTCCCAGCTTAGGCTTCTGTGGGTCTGGAAGAGTCTGTGCTTAATGTTTGGAGAAAGGCAGGAATGCCAGTTCCCAGTCTCCTAAGACTGCAACCCCTCCCCCATCACCTTCCCCTCCCCCATGTCTATGCGCCACCTTGTGGCTATCTCTAGGACTACACTCAGAGGCTGTGAGTCTGGTGGTAACTGCTGAAGCCGCTAGCTCAACTGGGGCCTAGGTGGGCTGAGTTCC... |
Task1_train_24228 | A mutation found in THRA (thyroid hormone receptor alpha) on Chromosome 17 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; not provided | TTAGCTGCCCCATGCCTCAGTTTCCACATCTGTGAAATGGTGATTATTATAATTATTCCTTTTAGGATTATGGTCAGGATGAAATAAGACATGTAAAACATGTAGCCTGATGCCTGATCATATATTAAGTATTCAGTCATTATAGCTGCTACTACTGTTACTACCGTTGTTATTATTAGCTGACTTGGAGCTCTGGTTCTGGTCTATTCTCTGCTCAAGATGAAGGAAAAGCTTTGGGCCTGGGACTCAGGCACGGGCGGCCCCTCTTCCCCAAGCTGCCTTGGAGCTCCCCCTGGTGGGCAGGGAGCCTCAGTGAGAGG... | TTAGCTGCCCCATGCCTCAGTTTCCACATCTGTGAAATGGTGATTATTATAATTATTCCTTTTAGGATTATGGTCAGGATGAAATAAGACATGTAAAACATGTAGCCTGATGCCTGATCATATATTAAGTATTCAGTCATTATAGCTGCTACTACTGTTACTACCGTTGTTATTATTAGCTGACTTGGAGCTCTGGTTCTGGTCTATTCTCTGCTCAAGATGAAGGAAAAGCTTTGGGCCTGGGACTCAGGCACGGGCGGCCCCTCTTCCCCAAGCTGCCTTGGAGCTCCCCCTGGTGGGCAGGGAGCCTCAGTGAGAGG... |
Task1_train_24229 | A mutation found in THRA (thyroid hormone receptor alpha) on Chromosome 17 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Congenital nongoitrous hypothyroidism 6 | ATAGACACACACACACAGATACAGACACACACACACACACAGACATATACACCTAGCACACAGACACACAGATACATAGACACACACCTAGCACACAGACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGG... | ATAGACACACACACACAGATACAGACACACACACACACACAGACATATACACCTAGCACACAGACACACAGATACATAGACACACACCTAGCACACAGACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGG... |
Task1_train_24230 | Here is a genetic alteration in THRA (thyroid hormone receptor alpha) on Chromosome 17. Based on the data, is it a benign variant or a cause of disease? | Pathogenic; not provided | AGACATATACACCTAGCACACAGACACACAGATACATAGACACACACCTAGCACACAGACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGGCAGCCTGAAAGTTCTCATTTTCCAGAGCACTAGTGCTGGA... | AGACATATACACCTAGCACACAGACACACAGATACATAGACACACACCTAGCACACAGACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGGCAGCCTGAAAGTTCTCATTTTCCAGAGCACTAGTGCTGGA... |
Task1_train_24231 | A sequence alteration has been identified in THRA (thyroid hormone receptor alpha) on Chromosome 17. Is it disease-inducing or harmless? | Pathogenic; Congenital nongoitrous hypothyroidism 6 | ACACCTAGCACACAGACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGGCAGCCTGAAAGTTCTCATTTTCCAGAGCACTAGTGCTGGAGACAGGCTGCCCTACTAGCCATGTGACCTGGGGTAAGTTACCT... | ACACCTAGCACACAGACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGGCAGCCTGAAAGTTCTCATTTTCCAGAGCACTAGTGCTGGAGACAGGCTGCCCTACTAGCCATGTGACCTGGGGTAAGTTACCT... |
Task1_train_24232 | Consider this mutation in THRA (thyroid hormone receptor alpha) on Chromosome 17. Is this a benign change or a disease-causing variant? | Pathogenic; Congenital nongoitrous hypothyroidism 6 | GACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGGCAGCCTGAAAGTTCTCATTTTCCAGAGCACTAGTGCTGGAGACAGGCTGCCCTACTAGCCATGTGACCTGGGGTAAGTTACCTCCATCCCCTGTGCC... | GACACACACACACAGACACACCCAGCACACAGGCACACACACACACACACACCTAGCAGACACACACATAGATACATACAGACACACACACAAACACACAGGCACACACACACAGCATACAGACACACGCCAAGGTCTGGCTGCTCTAAGAAATCAGCCGGCTCCAAGTGCTCCCCTCCACAGCCCCTCATCCTTCAAGTCTATGCGGCCACCCAACTCCAGGCAGCCTGAAAGTTCTCATTTTCCAGAGCACTAGTGCTGGAGACAGGCTGCCCTACTAGCCATGTGACCTGGGGTAAGTTACCTCCATCCCCTGTGCC... |
Task1_train_24233 | Consider this mutation in CDC6 (cell division cycle 6) on Chromosome 17. Is this a benign change or a disease-causing variant? | Pathogenic; Meier-Gorlin syndrome 5 | AAGAAAGAGGGCTAGGCACGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGTGGGTGGATCACCTAAGGTCAGGAGTTTGAGACCACCCTGGTCAACATGGTGAAACCCTGTCTCTACTAATAATACAAAAAAAAATTAGCCGGGCATGGTGGCAGGTGCCTATAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGGATCACTTGAACTCGGGAAGCAGAGGTTGCAGTGAGCTGAGATCGCGCTACTGTACTCCAGCCTGGGTGACAGAGTGAGACTCTGTCTCAAAAGAAAAAGAAGGCTGGGCATGG... | AAGAAAGAGGGCTAGGCACGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGTGGGTGGATCACCTAAGGTCAGGAGTTTGAGACCACCCTGGTCAACATGGTGAAACCCTGTCTCTACTAATAATACAAAAAAAAATTAGCCGGGCATGGTGGCAGGTGCCTATAATCCCAGCTACTCGGGAGGCTGAGGCAGGAGGATCACTTGAACTCGGGAAGCAGAGGTTGCAGTGAGCTGAGATCGCGCTACTGTACTCCAGCCTGGGTGACAGAGTGAGACTCTGTCTCAAAAGAAAAAGAAGGCTGGGCATGG... |
Task1_train_24234 | Given this context: Chromosome 17, gene SMARCE1 (SWI/SNF related BAF chromatin remodeling complex subunit E1) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Tessier cleft | TACAGGCGTGAGCCATGGCGCCTGGCAATGTCTATCTTTTGATAGTCCTCTGTTAAAGAAGTCAGTAGCTGTTGTACTTCATGCAGATGCCACCTTTCTGTTATGTACATTTGACATACATTTCCACCTCCCAAGTATTCCTCTTTCTAATCATTTTCGTACTGGTATGCTAAAGACATTCTCATATTGGCATCTTAATTGCTACCTGAATTTACTAGCAACTTTAAGACCCAATCTGAAAGTTAAAAACATCATAGGCCCAAGTTTCAGACTGTTTCTGAGTGAATCTCTTTAGTCCTTCTCAGTGTTCATGGTGTTAA... | TACAGGCGTGAGCCATGGCGCCTGGCAATGTCTATCTTTTGATAGTCCTCTGTTAAAGAAGTCAGTAGCTGTTGTACTTCATGCAGATGCCACCTTTCTGTTATGTACATTTGACATACATTTCCACCTCCCAAGTATTCCTCTTTCTAATCATTTTCGTACTGGTATGCTAAAGACATTCTCATATTGGCATCTTAATTGCTACCTGAATTTACTAGCAACTTTAAGACCCAATCTGAAAGTTAAAAACATCATAGGCCCAAGTTTCAGACTGTTTCTGAGTGAATCTCTTTAGTCCTTCTCAGTGTTCATGGTGTTAA... |
Task1_train_24235 | This mutation is located in gene SMARCE1 (SWI/SNF related BAF chromatin remodeling complex subunit E1) on Chromosome 17. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Coffin-Siris syndrome 5 | AATAGTAGCATGAGCTATATTTATACATTCTTATTGGATTTCTGAATTAAATGGAAAGGAAACTTCATGTTTCCACATACTCATTAGCTTCTCCCTTAAGAGCCTTTAATTCAGCGAATTTAGTGAACCAATAAGAAAACAAGATATAATTAGAATGCATTTAGCTTTTTAAAAGCAGATGAGGCAAAATCCTGATTGTGATTTAAAAACCTTTCGTGCATTTTGAGTACAAAGATTTTGATAAACAATCAATAATTTTTGCTATTTTCTGCACTGAAAAGGATATTTCTTTTTCTTGTGGGAAATTCACATACAAATCT... | AATAGTAGCATGAGCTATATTTATACATTCTTATTGGATTTCTGAATTAAATGGAAAGGAAACTTCATGTTTCCACATACTCATTAGCTTCTCCCTTAAGAGCCTTTAATTCAGCGAATTTAGTGAACCAATAAGAAAACAAGATATAATTAGAATGCATTTAGCTTTTTAAAAGCAGATGAGGCAAAATCCTGATTGTGATTTAAAAACCTTTCGTGCATTTTGAGTACAAAGATTTTGATAAACAATCAATAATTTTTGCTATTTTCTGCACTGAAAAGGATATTTCTTTTTCTTGTGGGAAATTCACATACAAATCT... |
Task1_train_24236 | Assess the clinical impact of this variant on gene KRT25 (keratin 25), found on Chromosome 17. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; Wooly hair, autosomal recessive 3 | GAGCTGGAGGCTATCATCCTTAGCAAGCTAACGCAGGAACAGAAAACCAAACACCACATGTTCTCACTTATAAGTGGGAGATAAATGATAAGGACTTATGAACACAAAGAAGGAAACAACAGATACTGGGTTCTACTTGAGGGGGAAGGGTGGGAGGAGGAAGAAGAGCAGAGAAGATAACTATTGGGTACCGGGCTTAATTCCTGGATGATCAAATAATATGCACAACAAACCTCCGTGACACGTGTTTACCTATGTAACAAACCTTCCAATGTACCCCCAAACCTAAATTAAAAGTTAAAAAATAAAAAATTAGCATT... | GAGCTGGAGGCTATCATCCTTAGCAAGCTAACGCAGGAACAGAAAACCAAACACCACATGTTCTCACTTATAAGTGGGAGATAAATGATAAGGACTTATGAACACAAAGAAGGAAACAACAGATACTGGGTTCTACTTGAGGGGGAAGGGTGGGAGGAGGAAGAAGAGCAGAGAAGATAACTATTGGGTACCGGGCTTAATTCCTGGATGATCAAATAATATGCACAACAAACCTCCGTGACACGTGTTTACCTATGTAACAAACCTTCCAATGTACCCCCAAACCTAAATTAAAAGTTAAAAAATAAAAAATTAGCATT... |
Task1_train_24237 | A mutation in KRT25 (keratin 25), located on Chromosome 17, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Autosomal Recessive Hypotrichosis with Woolly Hair | CAACAGATTTCATTTTAATTACCTTTGACTTGACTTCCCACATTTCCAGATCCATAATCTTTAGACTTGTAACCCCCAGACTTACAGGCTCTGTGAAAACATCGCAAAAGAGGGTGATTTAGAGAGAACCCCATCAATTCTAGGATCACCATATGGTTTTCTTTAGCTCTTTGGTAGTTTCAACTGTGTAACCCAGTATTTGATTTATAGTGTTTGCTGATTTCTGTAGAGGTATGAATACCTTCTCCATTGCTGATATCAAGTCACCAAGTGACATCACTAAGTGAGGGGTTAGGAAGAGAAGAGATAGGCAGAAGAGG... | CAACAGATTTCATTTTAATTACCTTTGACTTGACTTCCCACATTTCCAGATCCATAATCTTTAGACTTGTAACCCCCAGACTTACAGGCTCTGTGAAAACATCGCAAAAGAGGGTGATTTAGAGAGAACCCCATCAATTCTAGGATCACCATATGGTTTTCTTTAGCTCTTTGGTAGTTTCAACTGTGTAACCCAGTATTTGATTTATAGTGTTTGCTGATTTCTGTAGAGGTATGAATACCTTCTCCATTGCTGATATCAAGTCACCAAGTGACATCACTAAGTGAGGGGTTAGGAAGAGAAGAGATAGGCAGAAGAGG... |
Task1_train_24238 | A mutation on Chromosome 17 affecting KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; not provided | CTGAGGGATGTGACTGGGCTATGAAAGTACAAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTT... | CTGAGGGATGTGACTGGGCTATGAAAGTACAAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTT... |
Task1_train_24239 | A mutation on Chromosome 17 affecting KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; not provided | TGTGACTGGGCTATGAAAGTACAAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTTGGGGGTTT... | TGTGACTGGGCTATGAAAGTACAAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTTGGGGGTTT... |
Task1_train_24240 | A variant on Chromosome 17 in gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) has been observed. Is this a neutral mutation, or does it result in a disease? If so, which one? | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | ATGAAAGTACAAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTTGGGGGTTTTATTTGAGATAT... | ATGAAAGTACAAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTTGGGGGTTTTATTTGAGATAT... |
Task1_train_24241 | A variant found in Chromosome 17 affects KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; Epidermolytic hyperkeratosis 1 | AAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTTGGGGGTTTTATTTGAGATATTCCAGAATTT... | AAGGTCTTTAGTCCTGATCACTGGGCACAGTTGGGGAAGGCAGAGACCTAGTGGTGTCCTTTTGGTTACACTGGCATCACTACTTCCTGACAGCGTTTCTCACGTTCATCTGATGGACATCAAATAATTTTGTTGGGGGTGATATGATTTTACTTGGGTGGTGTCAGAAGATATGTCAAGCTATATAACAATTGGGAAGAAGTAATATAGTAACTGGAAGAAAGTAAGAAAAGGCAAAGGTGAGAAGTCAGGTAATTAGAAAATATAAAATTTCCAATTATTATTATTTTGGGGGTTTTATTTGAGATATTCCAGAATTT... |
Task1_train_24242 | Gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) on Chromosome 17 is impacted by this variant. Evaluate whether it is clinically benign or pathogenic and name the disorder if relevant. | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | AGTTGGGACTGTAGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCAT... | AGTTGGGACTGTAGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCAT... |
Task1_train_24243 | This sequence variant lies in KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) on Chromosome 17. Is it clinically significant, and what condition might it cause if any? | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | GGGACTGTAGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCC... | GGGACTGTAGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCC... |
Task1_train_24244 | This variant affects gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) located on Chromosome 17. Evaluate its biological effect and specify any disease association. | Pathogenic; not provided | GTAGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTC... | GTAGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTC... |
Task1_train_24245 | A mutation in KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1), located on Chromosome 17, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Congenital reticular ichthyosiform erythroderma | AGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCAC... | AGTTCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCAC... |
Task1_train_24246 | The gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) is located on Chromosome 17, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; not provided | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... |
Task1_train_24247 | A change on Chromosome 17 affects gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1). Identify whether the variant is neutral or disease-linked. Mention the disease if applicable. | Pathogenic; Epidermolytic ichthyosis | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... |
Task1_train_24248 | Here is a mutation in KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) on Chromosome 17. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... |
Task1_train_24249 | This is a variant in KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1), located on Chromosome 17. Is this mutation a likely cause of disease or not? | Pathogenic; Epidermolytic hyperkeratosis 1 | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... | TCTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATC... |
Task1_train_24250 | The variant affects gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24251 | Given this context: Chromosome 17, gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Congenital reticular ichthyosiform erythroderma | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24252 | This alteration in KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) on Chromosome 17 may affect gene function. Does it lead to a disease or is it benign? | Pathogenic; Epidermolytic ichthyosis | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24253 | This genomic variant is located on Chromosome 17, within the KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) gene. Can you determine its pathogenicity and name any linked disease? | Pathogenic; Annular epidermolytic ichthyosis | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24254 | The gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) is located on Chromosome 17, where a mutation has occurred. What is the medical relevance of this mutation? | Pathogenic; Autosomal dominant epidermolytic ichthyosis | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24255 | This mutation is located in gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) on Chromosome 17. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Epidermolytic nevus | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24256 | A genetic alteration is present in KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1) on Chromosome 17. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; KRT10-related disorder | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... | CTATCTCCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCA... |
Task1_train_24257 | A change on Chromosome 17 affects gene KRT10-AS1, KRT10 (KRT10 antisense RNA 1| keratin 10). Identify whether the variant is neutral or disease-linked. Mention the disease if applicable. | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | CCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCACCAGTG... | CCAGAGCTTGTACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCACCAGTG... |
Task1_train_24258 | The variant affects gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Epidermolytic hyperkeratosis 2A, autosomal dominant | ACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCACCAGTGGACACATTTCG... | ACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCACCAGTGGACACATTTCG... |
Task1_train_24259 | The gene KRT10, KRT10-AS1 (keratin 10| KRT10 antisense RNA 1), on Chromosome 17, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; not provided | ACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCACCAGTGGACACATTTCG... | ACATTACGTCTCAATTCAGTAATCTCAGATTTATAGCTGGATATCTGTTCAATGTTATTATCAATTTCTGTAGTCAGTTCCTTGCTCTAGAGTATTAAAAACAAGGAAAAGGGTGAGGAAATTCTGAAATGATAAAACCTCCATGAGTTTCACTATAAGGAAGATTACTTTACCTTTTCATTGAACCAGGCTTCAGCATCTTTGCGGTTTTGTTCAGCAAGTTGTTCATATTGGCTTCTCATGTTATTCAGAAGTTGAGTCAGATCAACACCCGGGGCAGCATTCATTTCCACATTCACATCACCAGTGGACACATTTCG... |
Task1_train_24260 | The gene KRT12 (keratin 12), on Chromosome 17, contains a mutation. Does this mutation cause a disorder, or is it a benign change? | Pathogenic; Corneal dystrophy, Meesmann, 1 | TGGGGGTCTCTCTATGTTGTCCAGGCTGGTCTTGAACTCCGGGCCTCAAGCAATCATCTTGCCTCTCAGCCTCCCAAAGTGCTGGGATTATAGGTGTGAGTCATTACTCCCAGCCTCTATTTTATTAGTAGTATTTCAAAAACTTCTCTCTATGCTCTTGACATTCTTGTTGGAATCAAGGCATACATTTCACATTATTACCATTCATCTTTTATTACAATTAACTCTATTAAAACAATACTACTTGATTAAAGCTCTATGATTAAAAAATATTCCGGGTTACCAGAAGAAAGTTCGTTAAAAGACTACTCCAGGTCCAG... | TGGGGGTCTCTCTATGTTGTCCAGGCTGGTCTTGAACTCCGGGCCTCAAGCAATCATCTTGCCTCTCAGCCTCCCAAAGTGCTGGGATTATAGGTGTGAGTCATTACTCCCAGCCTCTATTTTATTAGTAGTATTTCAAAAACTTCTCTCTATGCTCTTGACATTCTTGTTGGAATCAAGGCATACATTTCACATTATTACCATTCATCTTTTATTACAATTAACTCTATTAAAACAATACTACTTGATTAAAGCTCTATGATTAAAAAATATTCCGGGTTACCAGAAGAAAGTTCGTTAAAAGACTACTCCAGGTCCAG... |
Task1_train_24261 | A variant on Chromosome 17 in gene KRT12 (keratin 12) has been observed. Is this a neutral mutation, or does it result in a disease? If so, which one? | Pathogenic; Corneal dystrophy, Meesmann, 1 | TGTCCTGACTCCAGATTTCTAAATTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGG... | TGTCCTGACTCCAGATTTCTAAATTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGG... |
Task1_train_24262 | A variant found in Chromosome 17 affects KRT12 (keratin 12). Please analyze its biological impact: is it benign or pathogenic, and what condition might it cause? | Pathogenic; Corneal dystrophy, Meesmann, 1 | CTCCAGATTTCTAAATTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTC... | CTCCAGATTTCTAAATTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTC... |
Task1_train_24263 | Given this context: Chromosome 17, gene KRT12 (keratin 12) — does this variant present pathogenic behavior, and if so, what disease does it relate to? | Pathogenic; Corneal dystrophy, Meesmann, 1 | TTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTG... | TTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTG... |
Task1_train_24264 | Gene KRT12 (keratin 12), found on Chromosome 17, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; Corneal dystrophy, Meesmann, 1 | TTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTG... | TTTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTG... |
Task1_train_24265 | Consider this mutation in KRT12 (keratin 12) on Chromosome 17. Is this a benign change or a disease-causing variant? | Pathogenic; Corneal dystrophy, Meesmann, 1 | TTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTGC... | TTGAAATTGTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTGC... |
Task1_train_24266 | Consider this mutation in KRT12 (keratin 12) on Chromosome 17. Is this a benign change or a disease-causing variant? | Pathogenic; Corneal dystrophy, Meesmann, 1 | GTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTGCACCTACTT... | GTAATTTTTGGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTGCACCTACTT... |
Task1_train_24267 | This mutation occurs in KRT12 (keratin 12) on Chromosome 17. Does this change lead to a known medical condition, or is it benign? | Pathogenic; not provided | GGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTGCACCTACTTAATAATGGC... | GGGTCTGGGAGAAAAAAAAAAGTAGCTGAGTGAGGCTGCCCTGTCTGACTCACATCCTCGTGGTTCTTCTTCATGTAGGCCAGCTCCTCGTTCAGGCTCTCGATCTGCATCTCCAGGTCGGTCCTGGTCAGGGTCAGCTCGTCCAGCACCCGGCGCAGGCCATTGATGTCGGCCTCTACGCCCTGGCGCAGGGCCAGTTCATTCTCATACCTGAAAACCAAGTGCAAAGCAGTTGAGGGAATCAACACAACCATTTGAACAAGGCCACTGATCTTCAGGGCTATTTCTTGCTTAAATCTGTGCACCTACTTAATAATGGC... |
Task1_train_24268 | The gene KRT13 (keratin 13) on Chromosome 17 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; White sponge nevus 2 | CCTTGGCTCTGAGTGCTGGCAGAGTGTTCTGGAGAGTGTTTCCAGGTCCCACAGTGGAGGACTGTGTCCAGTTGCAGGGGAGGGCTCCTCCTTCTCACTGGAGGTTGTTGAGCCCAGGGCAGCCTGCAATTCCCGCTCACCTCTTCATGGTTCTTCTTCATGTAGGCTAGCTCTTCATTCAGGCTCTCGATCTGCATCTCCAGGTCAGTCTTAGACAGAGTGAGCTCATCCAGCACCCGGCGCAGGCCGTTGATGTCGGCCTCCACGCTCTGGCGCAGGGCCAGCTCATTCTCATACCTAAAATAGTAAAAAAATGAAAT... | CCTTGGCTCTGAGTGCTGGCAGAGTGTTCTGGAGAGTGTTTCCAGGTCCCACAGTGGAGGACTGTGTCCAGTTGCAGGGGAGGGCTCCTCCTTCTCACTGGAGGTTGTTGAGCCCAGGGCAGCCTGCAATTCCCGCTCACCTCTTCATGGTTCTTCTTCATGTAGGCTAGCTCTTCATTCAGGCTCTCGATCTGCATCTCCAGGTCAGTCTTAGACAGAGTGAGCTCATCCAGCACCCGGCGCAGGCCGTTGATGTCGGCCTCCACGCTCTGGCGCAGGGCCAGCTCATTCTCATACCTAAAATAGTAAAAAAATGAAAT... |
Task1_train_24269 | Gene KRT13 (keratin 13), found on Chromosome 17, is impacted by this variant. What is the biological outcome — benign or pathogenic? | Pathogenic; White sponge nevus 2 | TGTTCTGGAGAGTGTTTCCAGGTCCCACAGTGGAGGACTGTGTCCAGTTGCAGGGGAGGGCTCCTCCTTCTCACTGGAGGTTGTTGAGCCCAGGGCAGCCTGCAATTCCCGCTCACCTCTTCATGGTTCTTCTTCATGTAGGCTAGCTCTTCATTCAGGCTCTCGATCTGCATCTCCAGGTCAGTCTTAGACAGAGTGAGCTCATCCAGCACCCGGCGCAGGCCGTTGATGTCGGCCTCCACGCTCTGGCGCAGGGCCAGCTCATTCTCATACCTAAAATAGTAAAAAAATGAAATGTTTTTTGAAAAAGCAAGACATAA... | TGTTCTGGAGAGTGTTTCCAGGTCCCACAGTGGAGGACTGTGTCCAGTTGCAGGGGAGGGCTCCTCCTTCTCACTGGAGGTTGTTGAGCCCAGGGCAGCCTGCAATTCCCGCTCACCTCTTCATGGTTCTTCTTCATGTAGGCTAGCTCTTCATTCAGGCTCTCGATCTGCATCTCCAGGTCAGTCTTAGACAGAGTGAGCTCATCCAGCACCCGGCGCAGGCCGTTGATGTCGGCCTCCACGCTCTGGCGCAGGGCCAGCTCATTCTCATACCTAAAATAGTAAAAAAATGAAATGTTTTTTGAAAAAGCAAGACATAA... |
Task1_train_24270 | A mutation in KRT9 (keratin 9), located on Chromosome 17, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; not provided | GAAGCCTGTGGAGAGATGGAAGGGAGATGAGGGGGAGAAGGGAGGACTGTAAGCAGGAGCAGAGAGGTTGGGACTTGGGGGAAGATGGGGAAACTCGAAGCAAGGACACTAGAGCTCAAAGAGCTGGACAATCCTGAGGTAGAAGGACCCTGGGGTCTCCCAATCTACTGGTCCCCATCTAATTCCTGAATCTCTGTTGCAGCAAACCTGACAGATGCACCCCCAAGTCTGAGGATGGGGGGCTTATGAGGCAGCCCCCTCCATTCAACAGATTTGTTAGTCAATTTTTTGTATATTGAGGCAAAAGATGGCCCCAGCCT... | GAAGCCTGTGGAGAGATGGAAGGGAGATGAGGGGGAGAAGGGAGGACTGTAAGCAGGAGCAGAGAGGTTGGGACTTGGGGGAAGATGGGGAAACTCGAAGCAAGGACACTAGAGCTCAAAGAGCTGGACAATCCTGAGGTAGAAGGACCCTGGGGTCTCCCAATCTACTGGTCCCCATCTAATTCCTGAATCTCTGTTGCAGCAAACCTGACAGATGCACCCCCAAGTCTGAGGATGGGGGGCTTATGAGGCAGCCCCCTCCATTCAACAGATTTGTTAGTCAATTTTTTGTATATTGAGGCAAAAGATGGCCCCAGCCT... |
Task1_train_24271 | This sequence change occurs on Chromosome 17, altering KRT9 (keratin 9). What is the medical significance of this variant — is it benign or linked to a disease? | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | GTCTCATATTGATTCTCGATGTCCTTTCTGTTCTTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCT... | GTCTCATATTGATTCTCGATGTCCTTTCTGTTCTTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCT... |
Task1_train_24272 | This mutation occurs in KRT9 (keratin 9) on Chromosome 17. Does this change lead to a known medical condition, or is it benign? | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | CATATTGATTCTCGATGTCCTTTCTGTTCTTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAG... | CATATTGATTCTCGATGTCCTTTCTGTTCTTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAG... |
Task1_train_24273 | The variant affects gene KRT9 (keratin 9), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | TTCTCGATGTCCTTTCTGTTCTTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGG... | TTCTCGATGTCCTTTCTGTTCTTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGG... |
Task1_train_24274 | Here is a mutation in KRT9 (keratin 9) on Chromosome 17. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | TTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAAT... | TTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAAT... |
Task1_train_24275 | Assess the clinical impact of this variant on gene KRT9 (keratin 9), found on Chromosome 17. State whether it’s pathogenic or benign, and the disease if applicable. | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | TTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAAT... | TTAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAAT... |
Task1_train_24276 | A genetic alteration is present in KRT9 (keratin 9) on Chromosome 17. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | TAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATG... | TAGCAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATG... |
Task1_train_24277 | The variant affects gene KRT9 (keratin 9), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | CAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTC... | CAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTC... |
Task1_train_24278 | This variant lies on Chromosome 17 and affects the gene KRT9 (keratin 9). Based on this context, is the mutation pathogenic or benign? If pathogenic, what disease does it cause? | Pathogenic; Epidermolytic palmoplantar keratoderma, 1 | CAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTC... | CAATGAGCTGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTC... |
Task1_train_24279 | A mutation found in KRT9 (keratin 9) on Chromosome 17 may be clinically relevant. Is it pathogenic or benign, and if the former, which disease is implicated? | Pathogenic; Palmoplantar keratoderma, epidermolytic | TGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTCCAAAGCTC... | TGCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTCCAAAGCTC... |
Task1_train_24280 | The gene KRT9 (keratin 9) on Chromosome 17 carries this variant. Does this mutation lead to a specific disease, or is it non-pathogenic? | Pathogenic; not provided | GCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTCCAAAGCTCC... | GCTCATACTCCTGACGCATGTCATTGAGGGTCTTGGTGAGATCTTTGCCAGGAGCAACGTTTATCTCCACATTGACATCTCCACTGTTCTGCCCAGTCAGCTGACTCATCTCCTGCCAGGGAAGAAGGGGAGATGAGGTCACGGATAAAGTCCTCTGCACCACCTTTCAGAATTCTCCCTCTGGTCCCCCCAGGGTACAAAAAGGGGACACAGTTGTGAAGCCAAAGCCCAACCACTACCATAGGTGATGCCAAGGAGAAGTTGAAAGTGTCCTCAAGAGCAAAGGAGAGGGTGTCTCCCAGGTAATGTTCCAAAGCTCC... |
Task1_train_24281 | This mutation is located in gene KRT14 (keratin 14) on Chromosome 17. Is it associated with a disease or is it a benign polymorphism? | Pathogenic; Epidermolysis bullosa simplex 1C, localized | ACCCACCTCTGGAATCTTCACCACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCC... | ACCCACCTCTGGAATCTTCACCACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCC... |
Task1_train_24282 | A variant was discovered on Chromosome 17, affecting KRT14 (keratin 14). What is its functional impact — neutral or pathogenic? State the disease if pathogenic. | Pathogenic; Epidermolysis bullosa simplex 1A, generalized severe | CTGGAATCTTCACCACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGAT... | CTGGAATCTTCACCACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGAT... |
Task1_train_24283 | A genomic change on Chromosome 17 affects KRT14 (keratin 14). Classify this variant as benign or pathogenic, and name the disease if relevant. | Pathogenic; Epidermolysis bullosa simplex | CCACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGT... | CCACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGT... |
Task1_train_24284 | A genetic alteration is present in KRT14 (keratin 14) on Chromosome 17. Is this variant benign or disease-causing, and if the latter, which condition is involved? | Pathogenic; not provided | CACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTA... | CACTTACTAGGGTGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTA... |
Task1_train_24285 | The variant affects gene KRT14 (keratin 14), which is on Chromosome 17. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary. | Pathogenic; not provided | TGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAG... | TGAGGCTCCTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAG... |
Task1_train_24286 | A mutation on Chromosome 17 affecting KRT14 (keratin 14) has been found. Is it harmful or harmless? What disease, if any, does it cause? | Pathogenic; Epidermolysis bullosa simplex | CTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCT... | CTTGCCTTCCCACTCCTTTTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCT... |
Task1_train_24287 | A variant affecting Chromosome 17, within the gene KRT14 (keratin 14), has been observed. Determine if it's benign or associated with disease. | Pathogenic; Epidermolysis bullosa simplex | TTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCA... | TTCTAGCCCCCCAAAGAGAAGGAAAGGCATTCCCCACCCAGGGGAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCA... |
Task1_train_24288 | This alteration in KRT14 (keratin 14) on Chromosome 17 may affect gene function. Does it lead to a disease or is it benign? | Pathogenic; Palmoplantar blistering | GAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTC... | GAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTC... |
Task1_train_24289 | This gene mutation involves KRT14 (keratin 14) on Chromosome 17. Is it associated with any clinical condition, or is it benign? | Pathogenic; Skin fragility with non-scarring blistering | GAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTC... | GAGTCTCCTACAGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTC... |
Task1_train_24290 | Given this variant in gene KRT14 (keratin 14) on Chromosome 17, classify it as benign or pathogenic. Include the disorder it may cause if applicable. | Pathogenic; not provided | AGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTCTCCCAACAAGC... | AGTCCTGGCTCTTAAGGTATAGTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTCTCCCAACAAGC... |
Task1_train_24291 | A variant has been detected on Chromosome 17 in KRT14 (keratin 14). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; not provided | GTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTCTCCCAACAAGCCCATGAGGTAGATACTATCAT... | GTCACTCATTGGATTCTTGTATCAACCTCAAGAGGCAGGGCTCAGCATCCTTACTATACAAGTAAAGACACTGAGACTCAGACTTTCCAAGCTCACATCTGTTACAGAACAGAGCCAGGGTTAGAAACCAGTCTATTCTCAAACCCTCTAAAAATGCTCTCATCGTGAATGGATAATCACCATGCCCTAGAGATAGTTTACCCAGTATCGCCAGCACAGCCATGCCTTGAGCCAGCACTATGCCAGGCCCTGTGCTGGAGGCCTTAAATGCATTCTTCCAGTGAATTCTCCCAACAAGCCCATGAGGTAGATACTATCAT... |
Task1_train_24292 | A variant was discovered in gene KRT14 (keratin 14), Chromosome 17. Please indicate if this mutation results in a known disease or if it's non-harmful. | Pathogenic; Epidermolysis bullosa simplex, Koebner type | GTAAGGAGCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACC... | GTAAGGAGCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACC... |
Task1_train_24293 | A mutation in KRT14 (keratin 14), located on Chromosome 17, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Epidermolysis bullosa simplex | GTAAGGAGCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACC... | GTAAGGAGCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACC... |
Task1_train_24294 | A mutation in KRT14 (keratin 14), located on Chromosome 17, is being studied. Determine whether it’s pathogenic or benign, and specify the linked disease. | Pathogenic; Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive | GTAAGGAGCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACC... | GTAAGGAGCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACC... |
Task1_train_24295 | Given a variant located on Chromosome 17 and affecting KRT14 (keratin 14), assess whether it is benign or pathogenic. Indicate the associated disease if pathogenic. | Pathogenic; Epidermolysis bullosa simplex, Koebner type | GCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACCTGAGCCC... | GCTCTAGGAGACCCATGAACCCCATGACATTGTATGCAAATGTATGTATGCTTATTTGAAGGTAGGGGGCAGAAGGAAAGATCTATAGCTTTCAATATTCTCCAAGGAATCCCTGATCACAAAAACATCAGGAATCCTTAACCTAACATAGTGCCTGACATAGAGGCACTCAATATCTGGTGAATGAATGGACACACATGAAAATGAGTGAGTAAATGAATGAATATCCCTCCGTACCCTAGGAGACACCACATATGACCTGGTACACACATCTATCTGTGTCTTCTGAGATGGCGAAAGATATCCTGGGACCTGAGCCC... |
Task1_train_24296 | The gene KRT14 (keratin 14) on Chromosome 17 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant. | Pathogenic; Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive | GCGCAGGCCATTGATGTCGGCTTCCACACTCATGCGCAGGTTCAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGA... | GCGCAGGCCATTGATGTCGGCTTCCACACTCATGCGCAGGTTCAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGA... |
Task1_train_24297 | This is a variant in KRT14 (keratin 14), located on Chromosome 17. Is this mutation a likely cause of disease or not? | Pathogenic; Epidermolysis bullosa simplex | CGCAGGTTCAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGAAGTCCTCCAACTATGATTCCTTCCTATACTTCAA... | CGCAGGTTCAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGAAGTCCTCCAACTATGATTCCTTCCTATACTTCAA... |
Task1_train_24298 | A variant has been detected on Chromosome 17 in KRT14 (keratin 14). What is its effect — pathogenic or benign? If pathogenic, name the disease. | Pathogenic; not provided | CGCAGGTTCAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGAAGTCCTCCAACTATGATTCCTTCCTATACTTCAA... | CGCAGGTTCAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGAAGTCCTCCAACTATGATTCCTTCCTATACTTCAA... |
Task1_train_24299 | Here is a mutation in KRT14 (keratin 14) on Chromosome 17. Determine whether it’s benign or pathogenic. If the latter, what disease does it cause? | Pathogenic; not provided | CAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGAAGTCCTCCAACTATGATTCCTTCCTATACTTCAAGGGCAGCT... | CAACTCTGTCTCATACCTGGAATGACCCCAGAGAAAAGGTATGAGACACCCATCCTGATCACAGCGAGGGCTTTGTTCTCTTCTCCCTGCAGCTTCTCCCAGAGCTGGTGCCTTGTGGGTGGTTTAAGGAGCCAATCTTGAAAATGGCGTGGTTGAACACAGTGCCCATTGATTGCTCAGATATGAACATTCCTGCGGGCTGGGGATAAGGCAGTTCATCTTGCTGCAGAAATCAGGAGGGGGTTGCACTTCTAGCTTCAGCCAACAAATAATGCAGAAGTCCTCCAACTATGATTCCTTCCTATACTTCAAGGGCAGCT... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.